Mauremys mutica isolate MM-2020 ecotype Southern chromosome 24, ASM2049712v1, whole genome shotgun sequence.
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Archelosauria; Testudinata; Testudines; Cryptodira; Durocryptodira; Testudinoidea; Geoemydidae; Geoemydinae; Mauremys.
REFSEQ INFORMATION: The reference sequence is identical to\nCM035656.1.\nAssembly name: ASM2049712v1\nThe genomic sequence for this RefSeq record is from the\nwhole-genome assembly released by the Institute of Zoology,\nGuangdong Academy of Science on 2021/10/14. The original\nwhole-genome shotgun project has the accession JAHDVG000000000.1.\n\n##Genome-Assembly-Data-START##\nAssembly Provider :: Institute of Zoology, Guangdong Academy\n of Science\nAssembly Method :: FALCON v. March-2021\nGenome Representation :: Full\nExpected Final Version :: Yes\nGenome Coverage :: 99.81x\nSequencing Technology :: PacBio\n##Genome-Assembly-Data-END##\n\n##Genome-Annotation-Data-START##\nAnnotation Provider :: NCBI\nAnnotation Status :: Full annotation\nAnnotation Name :: Mauremys mutica Annotation Release\n 100\nAnnotation Version :: 100\nAnnotation Pipeline :: NCBI eukaryotic genome annotation\n pipeline\nAnnotation Software Version :: 9.0\nAnnotation Method :: Best-placed RefSeq; Gnomon\nFeatures Annotated :: Gene; mRNA; CDS; ncRNA\n##Genome-Annotation-Data-END##
Derived by automated computational analysis using gene prediction method: Gnomon.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
uncharacterized LOC123356026, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized LOC123356026, transcript variant X9
uncharacterized LOC123356026, transcript variant X4
uncharacterized LOC123356026, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC123356026, transcript variant X3
uncharacterized LOC123356026, transcript variant X6
uncharacterized LOC123356026, transcript variant X7
uncharacterized LOC123356026, transcript variant X1
uncharacterized LOC123356026, transcript variant X2
uncharacterized LOC123356027, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
uncharacterized LOC123356027, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
uncharacterized LOC123356027, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
uncharacterized LOC123356027, transcript variant X3
uncharacterized LOC123356027, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 62 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 113 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 62 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
COORDINATES: polyA evidence [ECO:0006239]
calcium and integrin binding family member 3, transcript variant X5
calcium and integrin binding family member 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
calcium and integrin-binding family member 3 isoform X2
calcium and integrin binding family member 3, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
calcium and integrin binding family member 3, transcript variant X1
calcium and integrin binding family member 3, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
calcium and integrin binding family member 3, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
calcium and integrin binding family member 3, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
calcium and integrin-binding family member 3 isoform X4
calcium and integrin-binding family member 3 isoform X3
calcium and integrin-binding family member 3 isoform X1
family with sequence similarity 32 member A
adaptor related protein complex 1 subunit mu 1, transcript variant X1
adaptor related protein complex 1 subunit mu 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
epidermal growth factor receptor pathway substrate 15 like 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
epidermal growth factor receptor pathway substrate 15 like 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
epidermal growth factor receptor pathway substrate 15 like 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
epidermal growth factor receptor pathway substrate 15 like 1, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
epidermal growth factor receptor substrate 15-like 1 isoform X2
epidermal growth factor receptor substrate 15-like 1 isoform X1
epidermal growth factor receptor substrate 15-like 1 isoform X4
epidermal growth factor receptor pathway substrate 15 like 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
epidermal growth factor receptor substrate 15-like 1 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 36 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
chromosome 24 C19orf44 homolog, transcript variant X3
chromosome 24 C19orf44 homolog, transcript variant X1
chromosome 24 C19orf44 homolog, transcript variant X4
chromosome 24 C19orf44 homolog, transcript variant X2
uncharacterized protein C19orf44 homolog isoform X1
uncharacterized protein C19orf44 homolog isoform X2
calcium homeostasis endoplasmic reticulum protein, transcript variant X3
calcium homeostasis endoplasmic reticulum protein, transcript variant X1
calcium homeostasis endoplasmic reticulum protein isoform X3
calcium homeostasis endoplasmic reticulum protein isoform X1
calcium homeostasis endoplasmic reticulum protein, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
calcium homeostasis endoplasmic reticulum protein isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
mediator complex subunit 26, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
mediator complex subunit 26, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
mediator complex subunit 26, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
mediator complex subunit 26, transcript variant X6
mediator complex subunit 26, transcript variant X5
mediator complex subunit 26, transcript variant X4
mediator of RNA polymerase II transcription subunit 26 isoform X1
mediator of RNA polymerase II transcription subunit 26 isoform X3
mediator of RNA polymerase II transcription subunit 26 isoform X2
mediator of RNA polymerase II transcription subunit 26 isoform X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
transmembrane protein 38A, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
trimeric intracellular cation channel type A isoform X1
transmembrane protein 38A, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
trimeric intracellular cation channel type A isoform X2
C3 and PZP like alpha-2-macroglobulin domain containing 8, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 68% coverage of the annotated genomic feature by RNAseq alignments
C3 and PZP like alpha-2-macroglobulin domain containing 8, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
C3 and PZP like alpha-2-macroglobulin domain containing 8, transcript variant X5
C3 and PZP like alpha-2-macroglobulin domain containing 8, transcript variant X1
C3 and PZP like alpha-2-macroglobulin domain containing 8, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 58% coverage of the annotated genomic feature by RNAseq alignments
NACHT domain- and WD repeat-containing protein 1
C3 and PZP like alpha-2-macroglobulin domain containing 8, transcript variant X7
SIN3 transcription regulator family member B, transcript variant X3
SIN3 transcription regulator family member B, transcript variant X1
SIN3 transcription regulator family member B, transcript variant X2
paired amphipathic helix protein Sin3b isoform X1
paired amphipathic helix protein Sin3b isoform X2
paired amphipathic helix protein Sin3b isoform X3
C3 and PZP like alpha-2-macroglobulin domain containing 8, transcript variant X8
C3 and PZP-like alpha-2-macroglobulin domain-containing protein 8 isoform X2
C3 and PZP like alpha-2-macroglobulin domain containing 8, transcript variant X6
C3 and PZP like alpha-2-macroglobulin domain containing 8, transcript variant X9
C3 and PZP-like alpha-2-macroglobulin domain-containing protein 8 isoform X1
HAUS augmin like complex subunit 8, transcript variant X2
HAUS augmin like complex subunit 8, transcript variant X1
HAUS augmin like complex subunit 8, transcript variant X3
HAUS augmin-like complex subunit 8 isoform X2
HAUS augmin-like complex subunit 8 isoform X1
HAUS augmin like complex subunit 8, transcript variant X4
HAUS augmin like complex subunit 8, transcript variant X5
HAUS augmin-like complex subunit 8 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
unconventional SNARE in the ER 1, transcript variant X1
vesicle transport protein USE1 isoform X1
unconventional SNARE in the ER 1, transcript variant X3
unconventional SNARE in the ER 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
vesicle transport protein USE1 isoform X2
Rho/Rac guanine nucleotide exchange factor 18, transcript variant X2
Rho/Rac guanine nucleotide exchange factor 18, transcript variant X1
rho guanine nucleotide exchange factor 18 isoform X1
rho guanine nucleotide exchange factor 18 isoform X2
ectoderm-neural cortex protein 1-like, transcript variant X2
ectoderm-neural cortex protein 1-like, transcript variant X7
ectoderm-neural cortex protein 1-like, transcript variant X1
ectoderm-neural cortex protein 1-like, transcript variant X3
ectoderm-neural cortex protein 1-like, transcript variant X5
ectoderm-neural cortex protein 1-like, transcript variant X4
ectoderm-neural cortex protein 1-like, transcript variant X6
ectoderm-neural cortex protein 1-like isoform X1
ectoderm-neural cortex protein 1-like isoform X2
ectoderm-neural cortex protein 1-like isoform X3
ectoderm-neural cortex protein 1-like isoform X4
ectoderm-neural cortex protein 1-like, transcript variant X8
peroxisomal membrane protein 11C-like isoform X5
testis expressed 45, transcript variant X1
testis expressed 45, transcript variant X3
testis expressed 45, transcript variant X2
testis expressed 45, transcript variant X4
microtubule associated serine/threonine kinase 3, transcript variant X1
microtubule associated serine/threonine kinase 3, transcript variant X2
microtubule-associated serine/threonine-protein kinase 3 isoform X1
microtubule-associated serine/threonine-protein kinase 3 isoform X2
microtubule associated serine/threonine kinase 3, transcript variant X3
microtubule associated serine/threonine kinase 3, transcript variant X4
microtubule-associated serine/threonine-protein kinase 3 isoform X3
microtubule-associated serine/threonine-protein kinase 3 isoform X4
phosphoinositide-3-kinase regulatory subunit 2
phosphatidylinositol 3-kinase regulatory subunit beta
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
gamma-interferon-inducible lysosomal thiol reductase
MPV17 mitochondrial inner membrane protein like 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
phosphodiesterase 4C, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 48 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
phosphodiesterase 4C, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 51 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
phosphodiesterase 4C, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 50 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
phosphodiesterase 4C, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 49 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
phosphodiesterase 4C, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
cAMP-specific 3',5'-cyclic phosphodiesterase 4C isoform X1
cAMP-specific 3',5'-cyclic phosphodiesterase 4C isoform X3
cAMP-specific 3',5'-cyclic phosphodiesterase 4C isoform X4
cAMP-specific 3',5'-cyclic phosphodiesterase 4C isoform X2
cAMP-specific 3',5'-cyclic phosphodiesterase 4C isoform X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
JunD proto-oncogene, AP-1 transcription factor subunit
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 29 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
LSM4 homolog, U6 small nuclear RNA and mRNA degradation associated
U6 snRNA-associated Sm-like protein LSm4
pyroglutamyl-peptidase I, transcript variant X6
pyroglutamyl-peptidase I, transcript variant X5
pyroglutamyl-peptidase I, transcript variant X2
pyroglutamyl-peptidase I, transcript variant X1
pyroglutamyl-peptidase I, transcript variant X3
pyroglutamyl-peptidase I, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 92% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
single stranded DNA binding protein 4, transcript variant X2
single-stranded DNA-binding protein 4 isoform X2
single stranded DNA binding protein 4, transcript variant X7
single stranded DNA binding protein 4, transcript variant X4
single stranded DNA binding protein 4, transcript variant X3
single stranded DNA binding protein 4, transcript variant X1
single-stranded DNA-binding protein 4 isoform X1
single-stranded DNA-binding protein 4 isoform X3
single-stranded DNA-binding protein 4 isoform X4
single stranded DNA binding protein 4, transcript variant X6
single stranded DNA binding protein 4, transcript variant X5
single-stranded DNA-binding protein 4 isoform X5
single-stranded DNA-binding protein 4 isoform X6
FKBP prolyl isomerase 8, transcript variant X2
FKBP prolyl isomerase 8, transcript variant X5
FKBP prolyl isomerase 8, transcript variant X3
FKBP prolyl isomerase 8, transcript variant X4
FKBP prolyl isomerase 8, transcript variant X1
peptidyl-prolyl cis-trans isomerase FKBP8
KxDL motif containing 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
KxDL motif containing 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
KxDL motif containing 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
KxDL motif containing 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
ubiquitin A-52 residue ribosomal protein fusion product 1
required for excision 1-B domain containing
required for excision 1-B domain-containing protein
cytokine receptor like factor 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
cytokine receptor like factor 1, transcript variant X2
cytokine receptor-like factor 1 isoform X1
cytokine receptor-like factor 1 isoform X2
transmembrane protein 59 like, transcript variant X1
transmembrane protein 59 like, transcript variant X2
transmembrane protein 59 like, transcript variant X3
transmembrane protein 59 like, transcript variant X4
transmembrane protein 59 like, transcript variant X5
transmembrane protein 59-like isoform X1
transmembrane protein 59-like isoform X3
transmembrane protein 59-like isoform X2
transmembrane protein 59-like isoform X4
transmembrane protein 59-like isoform X5
kelch like family member 26, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
kelch like family member 26, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
kelch like family member 26, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
kelch like family member 26, transcript variant X4
CREB regulated transcription coactivator 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
CREB regulated transcription coactivator 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
CREB regulated transcription coactivator 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
CREB-regulated transcription coactivator 1 isoform X1
CREB-regulated transcription coactivator 1 isoform X3
CREB regulated transcription coactivator 1, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
CREB regulated transcription coactivator 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
CREB-regulated transcription coactivator 1 isoform X2
CREB-regulated transcription coactivator 1 isoform X4
cartilage oligomeric matrix protein, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
cartilage oligomeric matrix protein, transcript variant X11
cartilage oligomeric matrix protein, transcript variant X13
cartilage oligomeric matrix protein, transcript variant X12
cartilage oligomeric matrix protein, transcript variant X10
cartilage oligomeric matrix protein, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
cartilage oligomeric matrix protein, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
cartilage oligomeric matrix protein, transcript variant X5
cartilage oligomeric matrix protein, transcript variant X6
cartilage oligomeric matrix protein, transcript variant X8
cartilage oligomeric matrix protein, transcript variant X7
cartilage oligomeric matrix protein, transcript variant X9
cartilage oligomeric matrix protein, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
cartilage oligomeric matrix protein isoform X2
cartilage oligomeric matrix protein isoform X1
cartilage oligomeric matrix protein isoform X3
cartilage oligomeric matrix protein isoform X4
cartilage oligomeric matrix protein isoform X5
cartilage oligomeric matrix protein isoform X6
UPF1 RNA helicase and ATPase, transcript variant X1
UPF1 RNA helicase and ATPase, transcript variant X2
regulator of nonsense transcripts 1 isoform X1
regulator of nonsense transcripts 1 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
embryonic growth/differentiation factor 1
ceramide synthase 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
ceramide synthase 1, transcript variant X4
ceramide synthase 1, transcript variant X3
ceramide synthase 1, transcript variant X2
probable ATP-dependent RNA helicase DDX49
homer scaffold protein 3, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
homer scaffold protein 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
homer scaffold protein 3, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
homer scaffold protein 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
semaphorin-4E-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
semaphorin-4E-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
semaphorin-4E-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
SURP and G-patch domain containing 2, transcript variant X5
SURP and G-patch domain containing 2, transcript variant X3
SURP and G-patch domain containing 2, transcript variant X4
SURP and G-patch domain containing 2, transcript variant X2
SURP and G-patch domain containing 2, transcript variant X1
SURP and G-patch domain-containing protein 2
armadillo repeat containing 6, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
armadillo repeat containing 6, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
armadillo repeat containing 6, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
uncharacterized LOC123355908, transcript variant X1
uncharacterized LOC123355908, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
uncharacterized LOC123355908, transcript variant X3
uncharacterized protein LOC123355908 isoform X3
uncharacterized protein LOC123355908 isoform X2
uncharacterized protein LOC123355908 isoform X1
solute carrier family 25 member 42, transcript variant X3
solute carrier family 25 member 42, transcript variant X2
solute carrier family 25 member 42, transcript variant X1
mitochondrial coenzyme A transporter SLC25A42 isoform X1
mitochondrial coenzyme A transporter SLC25A42 isoform X2
transmembrane protein 161A, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
transmembrane protein 161A, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
transmembrane protein 161A, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
myocyte enhancer factor 2B, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
myocyte enhancer factor 2B, transcript variant X3
myocyte enhancer factor 2B, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
myocyte-specific enhancer factor 2B isoform X2
myocyte-specific enhancer factor 2B isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 91% coverage of the annotated genomic feature by RNAseq alignments
BLOC-1 related complex subunit 8, transcript variant X1
BLOC-1 related complex subunit 8, transcript variant X2
BLOC-1 related complex subunit 8, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
regulatory factor X associated ankyrin containing protein, transcript variant X2
regulatory factor X associated ankyrin containing protein, transcript variant X1
regulatory factor X associated ankyrin containing protein, transcript variant X5
regulatory factor X associated ankyrin containing protein, transcript variant X6
regulatory factor X associated ankyrin containing protein, transcript variant X8
regulatory factor X associated ankyrin containing protein, transcript variant X7
regulatory factor X associated ankyrin containing protein, transcript variant X9
regulatory factor X associated ankyrin containing protein, transcript variant X4
regulatory factor X associated ankyrin containing protein, transcript variant X3
nuclear receptor 2C2 associated protein, transcript variant X3
nuclear receptor 2C2 associated protein, transcript variant X2
nuclear receptor 2C2 associated protein, transcript variant X4
nuclear receptor 2C2 associated protein, transcript variant X1
nuclear receptor 2C2 associated protein, transcript variant X5
nuclear receptor 2C2 associated protein, transcript variant X6
nuclear receptor 2C2-associated protein isoform X2
nuclear receptor 2C2-associated protein isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 34 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 38 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
hyaluronan and proteoglycan link protein 4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
SURP and G-patch domain-containing protein 1
uncharacterized LOC123355852, transcript variant X2
uncharacterized LOC123355852, transcript variant X1
GATA zinc finger domain containing 2A, transcript variant X5
GATA zinc finger domain containing 2A, transcript variant X2
GATA zinc finger domain containing 2A, transcript variant X1
GATA zinc finger domain containing 2A, transcript variant X7
GATA zinc finger domain containing 2A, transcript variant X3
GATA zinc finger domain containing 2A, transcript variant X4
GATA zinc finger domain containing 2A, transcript variant X6
transcriptional repressor p66-alpha isoform X1
transcriptional repressor p66-alpha isoform X4
transcriptional repressor p66-alpha isoform X2
transcriptional repressor p66-alpha isoform X3
NADH:ubiquinone oxidoreductase subunit A13
NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 13
YjeF N-terminal domain containing 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
YjeF N-terminal domain containing 3, transcript variant X2
yjeF N-terminal domain-containing protein 3
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 5 bases in 3 codons; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 89% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 5 bases in 3 codons; substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: cartilage intermediate layer protein 2
golgin subfamily A member 1-like, transcript variant X4
golgin subfamily A member 1-like, transcript variant X3
golgin subfamily A member 1-like, transcript variant X1
golgin subfamily A member 1-like, transcript variant X2
coiled-coil domain-containing protein 194
tRNA modification GTPase GTPBP3, mitochondrial
DET1 and DDB1 associated 1, transcript variant X3
DET1 and DDB1 associated 1, transcript variant X2
DET1 and DDB1 associated 1, transcript variant X1
DET1- and DDB1-associated protein 1 isoform X2
DET1- and DDB1-associated protein 1 isoform X3
DET1- and DDB1-associated protein 1 isoform X1
39S ribosomal protein L34, mitochondrial
abhydrolase domain containing 8, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
abhydrolase domain containing 8, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
abhydrolase domain containing 8, transcript variant X6
abhydrolase domain containing 8, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
abhydrolase domain containing 8, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
abhydrolase domain containing 8, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
abhydrolase domain containing 8, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
abhydrolase domain containing 8, transcript variant X8
ankyrin repeat and LEM domain containing 1, transcript variant X1
ankyrin repeat and LEM domain containing 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
ankyrin repeat and LEM domain-containing protein 1 isoform X1
ankyrin repeat and LEM domain-containing protein 1 isoform X2
USH1 protein network component harmonin binding protein 1
Usher syndrome type-1C protein-binding protein 1
nuclear receptor subfamily 2 group F member 6, transcript variant X1
nuclear receptor subfamily 2 group F member 6, transcript variant X2
nuclear receptor subfamily 2 group F member 6
occludin/ELL domain containing 1, transcript variant X1
occludin/ELL domain containing 1, transcript variant X3
occludin/ELL domain containing 1, transcript variant X2
occludin/ELL domain-containing protein 1
potassium calcium-activated channel subfamily N member 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
potassium calcium-activated channel subfamily N member 1, transcript variant X1
potassium calcium-activated channel subfamily N member 1, transcript variant X4
potassium calcium-activated channel subfamily N member 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
potassium calcium-activated channel subfamily N member 1, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 32 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
small conductance calcium-activated potassium channel protein 1
coiled-coil domain containing 124, transcript variant X1
coiled-coil domain containing 124, transcript variant X2
coiled-coil domain-containing protein 124
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 37 Proteins, and 88% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 39 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3, transcript variant X2
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3, transcript variant X3
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase 3 isoform X2
N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase 3 isoform X1
N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase 3 isoform X3
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3, transcript variant X5
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3, transcript variant X6
FCH and mu domain containing endocytic adaptor 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
FCH and mu domain containing endocytic adaptor 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
zona pellucida sperm-binding protein 4-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
cocaine- and amphetamine-regulated transcript protein-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
survival motor neuron protein 1-like, transcript variant X1
survival motor neuron protein 1-like, transcript variant X2
survival motor neuron protein 1-like isoform X1
survival motor neuron protein-like isoform X2
survival motor neuron protein 1-like, transcript variant X3
survival motor neuron protein 1-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
survival motor neuron protein 1-like, transcript variant X4
survival motor neuron protein 1-like isoform X3
survival of motor neuron protein-like isoform X4
growth arrest and DNA damage inducible beta, transcript variant X1
growth arrest and DNA damage inducible beta, transcript variant X2
growth arrest and DNA damage-inducible protein GADD45 beta isoform X1
growth arrest and DNA damage-inducible protein GADD45 beta isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 87% coverage of the annotated genomic feature by RNAseq alignments
G protein subunit gamma 7, transcript variant X4
G protein subunit gamma 7, transcript variant X2
G protein subunit gamma 7, transcript variant X5
G protein subunit gamma 7, transcript variant X1
G protein subunit gamma 7, transcript variant X3
G protein subunit gamma 7, transcript variant X6
guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-7
DIRAS family GTPase 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 33 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
DIRAS family GTPase 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 33 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
solute carrier family 39 member 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
solute carrier family 39 member 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
small glutamine rich tetratricopeptide repeat co-chaperone alpha, transcript variant X3
small glutamine rich tetratricopeptide repeat co-chaperone alpha, transcript variant X1
small glutamine rich tetratricopeptide repeat co-chaperone alpha, transcript variant X2
small glutamine-rich tetratricopeptide repeat-containing protein alpha
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 35 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
inactive serine/threonine-protein kinase PLK5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 97% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 97% coverage of the annotated genomic feature by RNAseq alignments
proprotein convertase subtilisin/kexin type 4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 40 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
receptor accessory protein 6, transcript variant X1
receptor accessory protein 6, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
receptor expression-enhancing protein 6 isoform X1
receptor expression-enhancing protein 6 isoform X2
chromosome 24 C19orf25 homolog, transcript variant X2
chromosome 24 C19orf25 homolog, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
UPF0449 protein C19orf25 homolog isoform X2
chromosome 24 C19orf25 homolog, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
UPF0449 protein C19orf25 homolog isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
APC regulator of WNT signaling pathway 2, transcript variant X1
APC regulator of WNT signaling pathway 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
APC regulator of WNT signaling pathway 2, transcript variant X4
APC regulator of WNT signaling pathway 2, transcript variant X2
APC regulator of WNT signaling pathway 2, transcript variant X5
APC regulator of WNT signaling pathway 2, transcript variant X6
APC regulator of WNT signaling pathway 2, transcript variant X7
adenomatous polyposis coli protein 2 isoform X1
adenomatous polyposis coli protein 2 isoform X2
adenomatous polyposis coli protein 2 isoform X3
DAZ associated protein 1, transcript variant X5
DAZ associated protein 1, transcript variant X2
DAZ associated protein 1, transcript variant X1
DAZ associated protein 1, transcript variant X6
DAZ associated protein 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
DAZ associated protein 1, transcript variant X4
NADH:ubiquinone oxidoreductase core subunit S7
NADH dehydrogenase [ubiquinone] iron-sulfur protein 7, mitochondrial
Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA asparagine (anticodon GUU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA phenylalanine (anticodon GAA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
PWWP domain containing 3A, DNA repair factor, transcript variant X2
PWWP domain containing 3A, DNA repair factor, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
PWWP domain containing 3A, DNA repair factor, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
PWWP domain-containing DNA repair factor 3A
calcium/calmodulin-dependent protein kinase type IV-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
family with sequence similarity 174 member C
cold inducible RNA binding protein, transcript variant X3
cold inducible RNA binding protein, transcript variant X2
cold inducible RNA binding protein, transcript variant X1
cold-inducible RNA-binding protein isoform X2
cold-inducible RNA-binding protein isoform X1
ATP synthase subunit delta, mitochondrial
CACN subunit beta associated regulatory protein, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
CACN subunit beta associated regulatory protein, transcript variant X7
CACN subunit beta associated regulatory protein, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
CACN subunit beta associated regulatory protein, transcript variant X1
CACN subunit beta associated regulatory protein, transcript variant X6
voltage-dependent calcium channel beta subunit-associated regulatory protein isoform X1
voltage-dependent calcium channel beta subunit-associated regulatory protein isoform X3
CACN subunit beta associated regulatory protein, transcript variant X4
CACN subunit beta associated regulatory protein, transcript variant X9
CACN subunit beta associated regulatory protein, transcript variant X2
CACN subunit beta associated regulatory protein, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
voltage-dependent calcium channel beta subunit-associated regulatory protein isoform X2
voltage-dependent calcium channel beta subunit-associated regulatory protein isoform X4
serine/threonine kinase 11, transcript variant X1
serine/threonine-protein kinase STK11 isoform X1
serine/threonine kinase 11, transcript variant X2
serine/threonine-protein kinase STK11 isoform X2
strawberry notch homolog 2, transcript variant X2
strawberry notch homolog 2, transcript variant X1
strawberry notch homolog 2, transcript variant X7
strawberry notch homolog 2, transcript variant X3
strawberry notch homolog 2, transcript variant X5
strawberry notch homolog 2, transcript variant X6
strawberry notch homolog 2, transcript variant X4
protein strawberry notch homolog 2 isoform X1
protein strawberry notch homolog 2 isoform X2
strawberry notch homolog 2, transcript variant X8
protein strawberry notch homolog 2 isoform X3
strawberry notch homolog 2, transcript variant X9
protein strawberry notch homolog 2 isoform X4
phospholipid hydroperoxide glutathione peroxidase
DNA-directed RNA polymerases I, II, and III subunit RPABC1
Rho GTPase activating protein 45, transcript variant X2
Rho GTPase activating protein 45, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
rho GTPase-activating protein 45 isoform X2
rho GTPase-activating protein 45 isoform X1
ATP binding cassette subfamily A member 7, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 38 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
ATP binding cassette subfamily A member 7, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 38 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
ATP binding cassette subfamily A member 7, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
phospholipid-transporting ATPase ABCA7 isoform X1
phospholipid-transporting ATPase ABCA7 isoform X2
Derived by automated computational analysis using gene prediction method: cmsearch.
COORDINATES: nucleotide motif:Rfam:12.0:RF00026
transmembrane protein 259, transcript variant X1
transmembrane protein 259, transcript variant X2
glutamate ionotropic receptor NMDA type subunit 3B
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 42% coverage of the annotated genomic feature by RNAseq alignments
AT-rich interaction domain 3A, transcript variant X3
AT-rich interaction domain 3A, transcript variant X2
AT-rich interaction domain 3A, transcript variant X1
AT-rich interaction domain 3A, transcript variant X4
AT-rich interactive domain-containing protein 3A
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
mediator complex subunit 16, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 34 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
mediator complex subunit 16, transcript variant X2
mediator complex subunit 16, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 34 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
mediator complex subunit 16, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 34 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
mediator complex subunit 16, transcript variant X5
mediator of RNA polymerase II transcription subunit 16 isoform X1
mediator of RNA polymerase II transcription subunit 16 isoform X2
phospholipid phosphatase related 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
phospholipid phosphatase related 3, transcript variant X2
phospholipid phosphatase related 3, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
phospholipid phosphatase related 3, transcript variant X4
phospholipid phosphatase-related protein type 3
uncharacterized protein KIAA1958-like, transcript variant X2
uncharacterized protein KIAA1958-like, transcript variant X1
uncharacterized protein KIAA1958-like, transcript variant X5
uncharacterized protein KIAA1958-like, transcript variant X6
uncharacterized protein KIAA1958-like, transcript variant X3
uncharacterized protein KIAA1958-like, transcript variant X4
mitotic spindle positioning, transcript variant X1
mitotic spindle positioning, transcript variant X2
mitotic interactor and substrate of PLK1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
serine protease 57, transcript variant X2
serine protease 57, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
fibroblast growth factor 22, transcript variant X2
fibroblast growth factor 22, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 35 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
fibroblast growth factor 22, transcript variant X3
DNA-directed RNA polymerase, mitochondrial
hyperpolarization activated cyclic nucleotide gated potassium and sodium channel 2, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 30 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
hyperpolarization activated cyclic nucleotide gated potassium and sodium channel 2, transcript variant X1
hyperpolarization activated cyclic nucleotide gated potassium and sodium channel 2, transcript variant X2
hyperpolarization activated cyclic nucleotide gated potassium and sodium channel 2, transcript variant X3
hyperpolarization activated cyclic nucleotide gated potassium and sodium channel 2, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 2 isoform X2
potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 2 isoform X1
cell division cycle 34, ubiqiutin conjugating enzyme
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
tubulin polyglutamylase complex subunit 1, transcript variant X2
tubulin polyglutamylase complex subunit 1, transcript variant X1
tubulin polyglutamylase complex subunit 1 isoform X2
tubulin polyglutamylase complex subunit 1 isoform X1
mucosal vascular addressin cell adhesion molecule 1
mucosal addressin cell adhesion molecule 1
hippocampus abundant transcript 1 protein-like, transcript variant X2
hippocampus abundant transcript 1 protein-like, transcript variant X3
hippocampus abundant transcript 1 protein-like, transcript variant X4
hippocampus abundant transcript 1 protein-like, transcript variant X1
hippocampus abundant transcript 1 protein-like isoform X2
hippocampus abundant transcript 1 protein-like isoform X1
outer dense fiber of sperm tails 3 like 2
outer dense fiber protein 3-like protein 2
SHC adaptor protein 2, transcript variant X5
SHC adaptor protein 2, transcript variant X7
SHC adaptor protein 2, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
SHC adaptor protein 2, transcript variant X2
SHC adaptor protein 2, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
SHC adaptor protein 2, transcript variant X3
SHC adaptor protein 2, transcript variant X1
C2 calcium dependent domain containing 4C
C2 calcium-dependent domain-containing protein 4C
insulin gene enhancer protein ISL-2-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins
MIER family member 2, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
MIER family member 2, transcript variant X2
mesoderm induction early response protein 2 isoform X2
MIER family member 2, transcript variant X7
mesoderm induction early response protein 2 isoform X6
MIER family member 2, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
mesoderm induction early response protein 2 isoform X5
MIER family member 2, transcript variant X8
mesoderm induction early response protein 2 isoform X7
MIER family member 2, transcript variant X1
MIER family member 2, transcript variant X3
MIER family member 2, transcript variant X4
mesoderm induction early response protein 2 isoform X1
mesoderm induction early response protein 2 isoform X3
mesoderm induction early response protein 2 isoform X4
granulocyte colony-stimulating factor receptor-like, transcript variant X1
granulocyte colony-stimulating factor receptor-like, transcript variant X2
granulocyte colony-stimulating factor receptor-like isoform X1
interleukin-6 receptor subunit beta-like isoform X2
phospholipid phosphatase 2, transcript variant X2
phospholipid phosphatase 2, transcript variant X1
transducin-like enhancer protein 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 56 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
transducin-like enhancer protein 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
transducin-like enhancer protein 1 isoform X1
transducin-like enhancer protein 1 isoform X2
transducin-like enhancer protein 2, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
transducin-like enhancer protein 2, transcript variant X6
transducin-like enhancer protein 2, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
transducin-like enhancer protein 2, transcript variant X3
transducin-like enhancer protein 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
transducin-like enhancer protein 2, transcript variant X1
transducin-like enhancer protein 2 isoform X6
transducin-like enhancer protein 2 isoform X4
transducin-like enhancer protein 2 isoform X5
transducin-like enhancer protein 2 isoform X3
transducin-like enhancer protein 2 isoform X2
transducin-like enhancer protein 2 isoform X1
TLE family member 5, transcriptional modulator, transcript variant X2
TLE family member 5, transcriptional modulator, transcript variant X1
guanine nucleotide-binding protein subunit alpha-11
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 111 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
guanine nucleotide-binding protein subunit alpha-15
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 57% coverage of the annotated genomic feature by RNAseq alignments
mast cell protease 1A-like, transcript variant X3
mast cell protease 1A-like, transcript variant X2
mast cell protease 1A-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
sphingosine-1-phosphate receptor 4, transcript variant X2
sphingosine-1-phosphate receptor 4, transcript variant X1
sphingosine-1-phosphate receptor 4, transcript variant X3
sphingosine 1-phosphate receptor 4 isoform X1
sphingosine 1-phosphate receptor 4 isoform X2
activated RNA polymerase II transcriptional coactivator p15-like, transcript variant X1
activated RNA polymerase II transcriptional coactivator p15-like, transcript variant X2
activated RNA polymerase II transcriptional coactivator p15-like
CUGBP Elav-like family member 5, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 67 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
CUGBP Elav-like family member 5, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
CUGBP Elav-like family member 5, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 80 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
CUGBP Elav-like family member 5 isoform X1
CUGBP Elav-like family member 5 isoform X3
CUGBP Elav-like family member 5 isoform X2
hydroxysteroid 11-beta dehydrogenase 1 like, transcript variant X12
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
hydroxysteroid 11-beta-dehydrogenase 1-like protein isoform X3
hydroxysteroid 11-beta dehydrogenase 1 like, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
hydroxysteroid 11-beta dehydrogenase 1 like, transcript variant X5
hydroxysteroid 11-beta dehydrogenase 1 like, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
hydroxysteroid 11-beta dehydrogenase 1 like, transcript variant X4
hydroxysteroid 11-beta dehydrogenase 1 like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
hydroxysteroid 11-beta dehydrogenase 1 like, transcript variant X3
hydroxysteroid 11-beta dehydrogenase 1 like, transcript variant X6
hydroxysteroid 11-beta dehydrogenase 1 like, transcript variant X1
hydroxysteroid 11-beta dehydrogenase 1 like, transcript variant X9
hydroxysteroid 11-beta dehydrogenase 1 like, transcript variant X14
hydroxysteroid 11-beta dehydrogenase 1 like, transcript variant X11
hydroxysteroid 11-beta dehydrogenase 1 like, transcript variant X10
hydroxysteroid 11-beta dehydrogenase 1 like, transcript variant X15
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
hydroxysteroid 11-beta dehydrogenase 1 like, transcript variant X13
hydroxysteroid 11-beta-dehydrogenase 1-like protein isoform X1
hydroxysteroid 11-beta-dehydrogenase 1-like protein isoform X2
hydroxysteroid 11-beta-dehydrogenase 1-like protein isoform X4
hydroxysteroid 11-beta-dehydrogenase 1-like protein isoform X5
mitochondrial contact site and cristae organizing system subunit 13
disintegrin and metalloproteinase domain-containing protein 10-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 26% coverage of the annotated genomic feature by RNAseq alignments
scaffold attachment factor B1-like, transcript variant X1
scaffold attachment factor B1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
scaffold attachment factor B1-like isoform X1
scaffold attachment factor B1-like isoform X2
ubiquitin domain-containing protein TINCR-like
uncharacterized LOC123355935, transcript variant X1
uncharacterized LOC123355935, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
transfer RNA arginine (anticodon CCU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
protein tyrosine phosphatase receptor type S, transcript variant X1
protein tyrosine phosphatase receptor type S, transcript variant X5
protein tyrosine phosphatase receptor type S, transcript variant X3
protein tyrosine phosphatase receptor type S, transcript variant X6
protein tyrosine phosphatase receptor type S, transcript variant X4
protein tyrosine phosphatase receptor type S, transcript variant X7
protein tyrosine phosphatase receptor type S, transcript variant X8
protein tyrosine phosphatase receptor type S, transcript variant X2
receptor-type tyrosine-protein phosphatase S isoform X1
receptor-type tyrosine-protein phosphatase S isoform X4
receptor-type tyrosine-protein phosphatase S isoform X2
receptor-type tyrosine-protein phosphatase S isoform X5
receptor-type tyrosine-protein phosphatase S isoform X3
receptor-type tyrosine-protein phosphatase S isoform X6
receptor-type tyrosine-protein phosphatase S isoform X7
lysine demethylase 4B, transcript variant X1
lysine-specific demethylase 4B isoform X1
lysine demethylase 4B, transcript variant X2
lysine-specific demethylase 4B isoform X2
ubiquitin like with PHD and ring finger domains 1, transcript variant X3
ubiquitin like with PHD and ring finger domains 1, transcript variant X1
ubiquitin like with PHD and ring finger domains 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
TIR domain-containing adapter molecule 1
uncharacterized LOC123355987, transcript variant X1
uncharacterized LOC123355987, transcript variant X2
transfer RNA valine (anticodon CAC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA glycine (anticodon UCC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
dipeptidyl peptidase 9, transcript variant X2
dipeptidyl peptidase 9, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
dipeptidyl peptidase 9, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
dipeptidyl peptidase 9, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
procathepsin L-like, transcript variant X2
procathepsin L-like, transcript variant X4
procathepsin L-like, transcript variant X3
procathepsin L-like, transcript variant X1
TNF alpha induced protein 8 like 1, transcript variant X2
TNF alpha induced protein 8 like 1, transcript variant X3
TNF alpha induced protein 8 like 1, transcript variant X1
tumor necrosis factor alpha-induced protein 8-like protein 1 isoform X1
tumor necrosis factor alpha-induced protein 8-like protein 1 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 34 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
hepatoma-derived growth factor-related protein 2
UBX domain protein 6, transcript variant X3
UBX domain protein 6, transcript variant X6
UBX domain-containing protein 6 isoform X3
UBX domain protein 6, transcript variant X1
UBX domain protein 6, transcript variant X2
UBX domain-containing protein 6 isoform X1
UBX domain-containing protein 6 isoform X2
UBX domain protein 6, transcript variant X4
UBX domain protein 6, transcript variant X5
UBX domain-containing protein 6 isoform X4
UBX domain-containing protein 6 isoform X5
UBX domain-containing protein 6 isoform X6
SH3 domain containing GRB2 like 1, endophilin A2, transcript variant X2
SH3 domain containing GRB2 like 1, endophilin A2, transcript variant X1
SH3 domain containing GRB2 like 1, endophilin A2, transcript variant X3
SH3 domain containing GRB2 like 1, endophilin A2, transcript variant X4
MPN domain containing, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
MPN domain containing, transcript variant X1
MPN domain-containing protein isoform X2
MPN domain-containing protein isoform X1
signal transducing adaptor family member 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
fibronectin type III and SPRY domain containing 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
fibronectin type III and SPRY domain-containing protein 1
Src homology 2 domain containing transforming protein D
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 95% coverage of the annotated genomic feature by RNAseq alignments
ankyrin repeat domain-containing protein 24
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
NAD-dependent protein deacetylase sirtuin-6 isoform X1
NAD-dependent protein deacetylase sirtuin-6 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 10% coverage of the annotated genomic feature by RNAseq alignments
cAMP responsive element binding protein 3 like 3, transcript variant X3
cAMP responsive element binding protein 3 like 3, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
cAMP responsive element binding protein 3 like 3, transcript variant X5
cAMP responsive element binding protein 3 like 3, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
cAMP responsive element binding protein 3 like 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
cAMP responsive element binding protein 3 like 3, transcript variant X2
cyclic AMP-responsive element-binding protein 3-like protein 3 isoform X2
cyclic AMP-responsive element-binding protein 3-like protein 3 isoform X5
cyclic AMP-responsive element-binding protein 3-like protein 3 isoform X4
cyclic AMP-responsive element-binding protein 3-like protein 3 isoform X3
cyclic AMP-responsive element-binding protein 3-like protein 3 isoform X1
mitogen-activated protein kinase kinase 2
dual specificity mitogen-activated protein kinase kinase 2
zinc finger and BTB domain containing 7A, transcript variant X6
zinc finger and BTB domain containing 7A, transcript variant X3
zinc finger and BTB domain containing 7A, transcript variant X4
zinc finger and BTB domain containing 7A, transcript variant X1
zinc finger and BTB domain containing 7A, transcript variant X2
zinc finger and BTB domain containing 7A, transcript variant X5
zinc finger and BTB domain containing 7A, transcript variant X7
zinc finger and BTB domain-containing protein 7A isoform X1
zinc finger and BTB domain-containing protein 7A isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 32 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
eukaryotic translation elongation factor 2
COORDINATES: nucleotide motif:Rfam:12.0:RF00440
death associated protein kinase 3, transcript variant X1
death associated protein kinase 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 77% coverage of the annotated genomic feature by RNAseq alignments
ATCAY kinesin light chain interacting caytaxin
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 28 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT6-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 46 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT6-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 46 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT6-like isoform X1
4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT6-like isoform X2
3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 43 Proteins, and 45% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
dihydrouridine synthase 3 like, transcript variant X1
dihydrouridine synthase 3 like, transcript variant X2
tRNA-dihydrouridine(47) synthase [NAD(P)(+)]-like isoform X1
tRNA-dihydrouridine(47) synthase [NAD(P)(+)]-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 62% coverage of the annotated genomic feature by RNAseq alignments
regulatory factor X2, transcript variant X2
regulatory factor X2, transcript variant X1
regulatory factor X2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
regulatory factor X2, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
regulatory factor X2, transcript variant X4
acyl-CoA synthetase bubblegum family member 2, transcript variant X3
long-chain-fatty-acid--CoA ligase ACSBG2 isoform X3
acyl-CoA synthetase bubblegum family member 2, transcript variant X4
acyl-CoA synthetase bubblegum family member 2, transcript variant X5
acyl-CoA synthetase bubblegum family member 2, transcript variant X1
long-chain-fatty-acid--CoA ligase ACSBG2 isoform X1
acyl-CoA synthetase bubblegum family member 2, transcript variant X2
long-chain-fatty-acid--CoA ligase ACSBG2 isoform X2
long-chain-fatty-acid--CoA ligase ACSBG2 isoform X4
acyl-CoA synthetase bubblegum family member 2, transcript variant X7
acyl-CoA synthetase bubblegum family member 2, transcript variant X6
long-chain-fatty-acid--CoA ligase ACSBG2 isoform X5
MLLT1 super elongation complex subunit, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
MLLT1 super elongation complex subunit, transcript variant X3
MLLT1 super elongation complex subunit, transcript variant X4
MLLT1 super elongation complex subunit, transcript variant X2
MLLT1 super elongation complex subunit, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 49% coverage of the annotated genomic feature by RNAseq alignments
acidic leucine-rich nuclear phosphoprotein 32 family member B, transcript variant X1
acidic leucine-rich nuclear phosphoprotein 32 family member B, transcript variant X2
acidic leucine-rich nuclear phosphoprotein 32 family member B isoform X1
acidic leucine-rich nuclear phosphoprotein 32 family member B isoform X2
zinc finger protein 414, transcript variant X4
zinc finger protein 414, transcript variant X3
zinc finger protein 414, transcript variant X6
zinc finger protein 414, transcript variant X2
zinc finger protein 414, transcript variant X1
zinc finger protein 414, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
ADAM metallopeptidase with thrombospondin type 1 motif 10, transcript variant X2
ADAM metallopeptidase with thrombospondin type 1 motif 10, transcript variant X1
ADAM metallopeptidase with thrombospondin type 1 motif 10, transcript variant X3
A disintegrin and metalloproteinase with thrombospondin motifs 10 isoform X2
A disintegrin and metalloproteinase with thrombospondin motifs 10 isoform X1
A disintegrin and metalloproteinase with thrombospondin motifs 10 isoform X3
tyrosine-protein kinase ZAP-70, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
tyrosine-protein kinase ZAP-70, transcript variant X2
tyrosine-protein kinase ZAP-70, transcript variant X5
tyrosine-protein kinase ZAP-70 isoform X1
tyrosine-protein kinase ZAP-70, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
tyrosine-protein kinase ZAP-70, transcript variant X3
tyrosine-protein kinase ZAP-70 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 81% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 84% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 80% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 82% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 82% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 89% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 48% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 96% coverage of the annotated genomic feature by RNAseq alignments
C2 calcium-dependent domain-containing protein 4C-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC123355684, transcript variant X2
uncharacterized LOC123355684, transcript variant X1
uncharacterized LOC123355684, transcript variant X3
uncharacterized protein LOC123355684 isoform X1
uncharacterized protein LOC123355684 isoform X2
uncharacterized protein LOC123355684 isoform X3
leucine rich repeat and Ig domain containing 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 33 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
leucine rich repeat and Ig domain containing 3, transcript variant X1
leucine rich repeat and Ig domain containing 3, transcript variant X3
leucine rich repeat and Ig domain containing 3, transcript variant X4
leucine-rich repeat and immunoglobulin-like domain-containing nogo receptor-interacting protein 3
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: ornithine decarboxylase antizyme 1
junctional sarcoplasmic reticulum protein 1
splicing factor 3a subunit 2, transcript variant X1
splicing factor 3a subunit 2, transcript variant X2
splicing factor 3a subunit 2, transcript variant X3
pleckstrin homology domain containing J1
pleckstrin homology domain-containing family J member 1
DOT1 like histone lysine methyltransferase, transcript variant X6
DOT1 like histone lysine methyltransferase, transcript variant X4
DOT1 like histone lysine methyltransferase, transcript variant X3
DOT1 like histone lysine methyltransferase, transcript variant X2
DOT1 like histone lysine methyltransferase, transcript variant X1
DOT1 like histone lysine methyltransferase, transcript variant X7
DOT1 like histone lysine methyltransferase, transcript variant X5
histone-lysine N-methyltransferase, H3 lysine-79 specific isoform X6
histone-lysine N-methyltransferase, H3 lysine-79 specific isoform X2
histone-lysine N-methyltransferase, H3 lysine-79 specific isoform X3
histone-lysine N-methyltransferase, H3 lysine-79 specific isoform X4
histone-lysine N-methyltransferase, H3 lysine-79 specific isoform X1
histone-lysine N-methyltransferase, H3 lysine-79 specific isoform X5
adaptor related protein complex 3 subunit delta 1, transcript variant X1
adaptor related protein complex 3 subunit delta 1, transcript variant X2
adaptor related protein complex 3 subunit delta 1, transcript variant X3
IZUMO family member 4, transcript variant X2
IZUMO family member 4, transcript variant X1
izumo sperm-egg fusion protein 4 isoform X2
izumo sperm-egg fusion protein 4 isoform X1
MOB kinase activator 3A, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 43 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
MOB kinase activator 3A, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 43 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
MAPK interacting serine/threonine kinase 2
MAP kinase-interacting serine/threonine-protein kinase 2
BTB domain containing 2, transcript variant X1
BTB domain containing 2, transcript variant X3
BTB domain containing 2, transcript variant X2
BTB/POZ domain-containing protein 2 isoform X1
BTB/POZ domain-containing protein 2 isoform X3
BTB/POZ domain-containing protein 2 isoform X2
casein kinase 1 gamma 2, transcript variant X1
casein kinase 1 gamma 2, transcript variant X2
casein kinase 1 gamma 2, transcript variant X3
secretory carrier membrane protein 4, transcript variant X1
secretory carrier membrane protein 4, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
secretory carrier-associated membrane protein 4
nuclear receptor ROR-beta-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 58 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
nuclear receptor ROR-beta-like, transcript variant X2
nuclear receptor ROR-beta-like isoform X1
nuclear receptor ROR-beta-like isoform X2
uncharacterized LOC123356126, transcript variant X2
uncharacterized LOC123356126, transcript variant X1
uncharacterized LOC123355695, transcript variant X1
uncharacterized LOC123355695, transcript variant X2
AN1-type zinc finger protein 5-like, transcript variant X2
AN1-type zinc finger protein 5-like, transcript variant X3
AN1-type zinc finger protein 5-like, transcript variant X1
AN1-type zinc finger protein 5-like, transcript variant X4
AN1-type zinc finger protein 5-like isoform X1
AN1-type zinc finger protein 5-like isoform X2
abhydrolase domain containing 17A, depalmitoylase, transcript variant X2
abhydrolase domain containing 17A, depalmitoylase, transcript variant X1
alpha/beta hydrolase domain-containing protein 17A
RNA exonuclease 1 homolog, transcript variant X1
RNA exonuclease 1 homolog, transcript variant X2
ATPase phospholipid transporting 8B3, transcript variant X1
phospholipid-transporting ATPase IK isoform X1
ATPase phospholipid transporting 8B3, transcript variant X2
ATPase phospholipid transporting 8B3, transcript variant X3
ATPase phospholipid transporting 8B3, transcript variant X4
ATPase phospholipid transporting 8B3, transcript variant X5
phospholipid-transporting ATPase IK isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins
transcription factor 3, transcript variant X5
transcription factor 3, transcript variant X6
transcription factor 3, transcript variant X7
transcription factor 3, transcript variant X3
transcription factor 3, transcript variant X4
transcription factor 3, transcript variant X2
transcription factor 3, transcript variant X1
transcription factor E2-alpha isoform X1
transcription factor E2-alpha isoform X3
transcription factor E2-alpha isoform X5
transcription factor E2-alpha isoform X4
transcription factor E2-alpha isoform X6
transcription factor E2-alpha isoform X7
transcription factor E2-alpha isoform X2
uncharacterized LOC123356022, transcript variant X3
uncharacterized LOC123356023, transcript variant X1
uncharacterized LOC123356023, transcript variant X2
uncharacterized LOC123356022, transcript variant X1
uncharacterized LOC123356022, transcript variant X2
uncharacterized protein LOC123356022 isoform X1
uncharacterized protein LOC123356022 isoform X2
uncharacterized protein LOC123356022 isoform X3
methyl-CpG binding domain protein 3, transcript variant X2
methyl-CpG-binding domain protein 3 isoform X2
methyl-CpG binding domain protein 3, transcript variant X1
methyl-CpG binding domain protein 3, transcript variant X3
methyl-CpG-binding domain protein 3 isoform X1
methyl-CpG-binding domain protein 3 isoform X3
mex-3 RNA binding family member D, transcript variant X2
mex-3 RNA binding family member D, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 33 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
unconventional myosin-Va-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 33 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
unconventional myosin-Va-like, transcript variant X2
unconventional myosin-Va-like isoform X1
unconventional myosin-Va-like isoform X2
nuclear factor I C, transcript variant X1
nuclear factor I C, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
small integral membrane protein 24, transcript variant X2
small integral membrane protein 24, transcript variant X3
small integral membrane protein 24, transcript variant X1
small integral membrane protein 24 isoform X2
small integral membrane protein 24 isoform X3
small integral membrane protein 24 isoform X1
deoxyhypusine hydroxylase, transcript variant X2
deoxyhypusine hydroxylase, transcript variant X1
protein ANTAGONIST OF LIKE HETEROCHROMATIN PROTEIN 1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
protein ANTAGONIST OF LIKE HETEROCHROMATIN PROTEIN 1-like, transcript variant X1
protein ANTAGONIST OF LIKE HETEROCHROMATIN PROTEIN 1-like isoform X2
protein ANTAGONIST OF LIKE HETEROCHROMATIN PROTEIN 1-like isoform X1
fizzy and cell division cycle 20 related 1, transcript variant X2
fizzy and cell division cycle 20 related 1, transcript variant X1
fizzy and cell division cycle 20 related 1, transcript variant X4
fizzy and cell division cycle 20 related 1, transcript variant X5
fizzy and cell division cycle 20 related 1, transcript variant X3
fizzy and cell division cycle 20 related 1, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
uncharacterized protein C19orf71 homolog
major facilitator superfamily domain containing 12
major facilitator superfamily domain-containing protein 12
high mobility group 20B, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
high mobility group 20B, transcript variant X2
SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily E member 1-related
GIPC PDZ domain containing family member 3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
thromboxane A2 receptor, transcript variant X2
thromboxane A2 receptor, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
phosphatidylinositol-4-phosphate 5-kinase type 1 gamma, transcript variant X2
phosphatidylinositol-4-phosphate 5-kinase type 1 gamma, transcript variant X1
phosphatidylinositol-4-phosphate 5-kinase type 1 gamma, transcript variant X3
phosphatidylinositol-4-phosphate 5-kinase type 1 gamma, transcript variant X4
phosphatidylinositol 4-phosphate 5-kinase type-1 gamma isoform X4
phosphatidylinositol 4-phosphate 5-kinase type-1 gamma isoform X3
phosphatidylinositol 4-phosphate 5-kinase type-1 gamma isoform X2
phosphatidylinositol 4-phosphate 5-kinase type-1 gamma isoform X1
tight junction protein 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 30 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
tight junction protein 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 32 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
amyloid beta precursor protein binding family A member 3
amyloid-beta A4 precursor protein-binding family A member 3
39S ribosomal protein L54, mitochondrial
mucosa-associated lymphoid tissue lymphoma translocation protein 1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
mucosa-associated lymphoid tissue lymphoma translocation protein 1-like, transcript variant X2
mucosa-associated lymphoid tissue lymphoma translocation protein 1-like
retina and anterior neural fold homeobox 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 93% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
retina and anterior neural fold homeobox protein 2
megakaryocyte-associated tyrosine kinase, transcript variant X6
megakaryocyte-associated tyrosine kinase, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 35 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
megakaryocyte-associated tyrosine kinase, transcript variant X3
megakaryocyte-associated tyrosine kinase, transcript variant X2
megakaryocyte-associated tyrosine kinase, transcript variant X5
megakaryocyte-associated tyrosine kinase, transcript variant X4
megakaryocyte-associated tyrosine-protein kinase isoform X2
megakaryocyte-associated tyrosine-protein kinase isoform X1
zinc finger RNA binding protein 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
zinc finger RNA binding protein 2, transcript variant X2
zinc finger RNA-binding protein 2 isoform X2
zinc finger RNA-binding protein 2 isoform X1
ELAV like RNA binding protein 1, transcript variant X1
ELAV like RNA binding protein 1, transcript variant X2
ELAV like RNA binding protein 1, transcript variant X3
excitatory amino acid transporter 5-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 52 Proteins, and 34% coverage of the annotated genomic feature by RNAseq alignments
PML-RARA regulated adaptor molecule 1, transcript variant X3
PML-RARA regulated adaptor molecule 1, transcript variant X1
PML-RARA regulated adaptor molecule 1, transcript variant X2
PML-RARA-regulated adapter molecule 1 isoform X1
PML-RARA-regulated adapter molecule 1 isoform X2
DNA polymerase epsilon 4, accessory subunit, transcript variant X2
DNA polymerase epsilon 4, accessory subunit, transcript variant X1
DNA polymerase epsilon subunit 4 isoform X2
DNA polymerase epsilon subunit 4 isoform X1
bone morphogenetic protein 2-like, transcript variant X1
bone morphogenetic protein 2-like, transcript variant X2
potassium voltage-gated channel subfamily V member 2-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 49% coverage of the annotated genomic feature by RNAseq alignments
NADH:ubiquinone oxidoreductase subunit A7
NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 7
KN motif and ankyrin repeat domains 3, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
KN motif and ankyrin repeat domains 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 28 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
KN motif and ankyrin repeat domains 3, transcript variant X2
KN motif and ankyrin repeat domain-containing protein 3 isoform X2
KN motif and ankyrin repeat domain-containing protein 3 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 118 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
membrane associated ring-CH-type finger 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
membrane associated ring-CH-type finger 2, transcript variant X2
membrane associated ring-CH-type finger 2, transcript variant X1
E3 ubiquitin-protein ligase MARCHF2 isoform X2
E3 ubiquitin-protein ligase MARCHF2 isoform X1
heterogeneous nuclear ribonucleoprotein M, transcript variant X3
heterogeneous nuclear ribonucleoprotein M, transcript variant X1
heterogeneous nuclear ribonucleoprotein M isoform X1
heterogeneous nuclear ribonucleoprotein M isoform X3
heterogeneous nuclear ribonucleoprotein M, transcript variant X2
heterogeneous nuclear ribonucleoprotein M isoform X2
translocase of inner mitochondrial membrane 44, transcript variant X1
mitochondrial import inner membrane translocase subunit TIM44 isoform X1
translocase of inner mitochondrial membrane 44, transcript variant X2
mitochondrial import inner membrane translocase subunit TIM44 isoform X2
maestro heat-like repeat-containing protein family member 2B
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 99% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
maestro heat-like repeat-containing protein family member 2B, transcript variant X1
maestro heat-like repeat-containing protein family member 2B, transcript variant X2
maestro heat-like repeat-containing protein family member 2B isoform X2
maestro heat-like repeat-containing protein family member 2B isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
transfer RNA alanine (anticodon UGC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA arginine (anticodon UCU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA threonine (anticodon UGU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA serine (anticodon AGA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA glutamine (anticodon CUG); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA lysine (anticodon CUU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA tryptophan (anticodon CCA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
uncharacterized LOC123356019, transcript variant X1
uncharacterized LOC123356019, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
uncharacterized LOC123355730, transcript variant X2
uncharacterized LOC123355730, transcript variant X1
uncharacterized LOC123355951, transcript variant X5
uncharacterized LOC123355951, transcript variant X3
uncharacterized LOC123355951, transcript variant X4
uncharacterized LOC123355951, transcript variant X6
uncharacterized LOC123355951, transcript variant X2
uncharacterized LOC123355951, transcript variant X1
ribosomal protein L36, transcript variant X1
ribosomal protein L36, transcript variant X3
ribosomal protein L36, transcript variant X2
uncharacterized LOC123355952, transcript variant X2
uncharacterized LOC123355952, transcript variant X1
excitatory amino acid transporter 1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 88 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
excitatory amino acid transporter 1-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 88 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
excitatory amino acid transporter 1-like, transcript variant X3
excitatory amino acid transporter 1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 88 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
excitatory amino acid transporter 1-like isoform X2
excitatory amino acid transporter 1-like isoform X1
excitatory amino acid transporter 1-like isoform X3
RAN binding protein 3, transcript variant X1
RAN binding protein 3, transcript variant X2
RAN binding protein 3, transcript variant X3
vimentin type intermediate filament associated coiled-coil protein
vimentin-type intermediate filament-associated coiled-coil protein
NADH:ubiquinone oxidoreductase subunit A11
NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 11
maestro heat-like repeat family member 5, transcript variant X1
maestro heat-like repeat family member 5, transcript variant X2
maestro heat-like repeat family member 5 isoform X1
maestro heat-like repeat family member 5 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 28 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
translocase of inner mitochondrial membrane 13
mitochondrial import inner membrane translocase subunit Tim13
signal peptide peptidase like 2B, transcript variant X2
signal peptide peptidase like 2B, transcript variant X1
signal peptide peptidase like 2B, transcript variant X3
signal peptide peptidase-like 2B isoform X2
signal peptide peptidase-like 2B isoform X1
signal peptide peptidase-like 2B isoform X3
signal peptide peptidase like 2B, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
signal peptide peptidase-like 2B isoform X4
LSM7 homolog, U6 small nuclear RNA and mRNA degradation associated, transcript variant X2
LSM7 homolog, U6 small nuclear RNA and mRNA degradation associated, transcript variant X1
U6 snRNA-associated Sm-like protein LSm7 isoform X1
U6 snRNA-associated Sm-like protein LSm7 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
transfer RNA valine (anticodon AAC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA lysine (anticodon UUU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA cysteine (anticodon GCA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA glutamic acid (anticodon UUC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA serine (anticodon GCU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
COORDINATES: nucleotide motif:Rfam:12.0:RF00004
transfer RNA isoleucine (anticodon UAU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA serine (anticodon UGA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
ribosomal biogenesis protein LAS1L-like, transcript variant X3
ribosomal biogenesis protein LAS1L-like, transcript variant X4
ribosomal biogenesis protein LAS1L-like, transcript variant X11
ribosomal biogenesis protein LAS1L-like, transcript variant X10
ribosomal biogenesis protein LAS1L-like, transcript variant X7
ribosomal biogenesis protein LAS1L-like, transcript variant X6
ribosomal biogenesis protein LAS1L-like, transcript variant X2
ribosomal biogenesis protein LAS1L-like, transcript variant X1
ribosomal biogenesis protein LAS1L-like, transcript variant X5
ribosomal biogenesis protein LAS1L-like, transcript variant X8
ribosomal biogenesis protein LAS1L-like, transcript variant X9
coiled-coil domain-containing glutamate-rich protein 1-like isoform X2
cyclic nucleotide-gated cation channel beta-1-like isoform X1
ribosomal biogenesis protein LAS1L-like isoform X3
maestro heat-like repeat family member 5, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 92% coverage of the annotated genomic feature by RNAseq alignments
adhesion G protein-coupled receptor E1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 84% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 57% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
major histocompatibility complex class I-related gene protein-like
class I histocompatibility antigen, Gogo-B*0103 alpha chain-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 70% coverage of the annotated genomic feature by RNAseq alignments
class I histocompatibility antigen, F10 alpha chain-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 98% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
volume-regulated anion channel subunit LRRC8A